<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ADiabetic_nephropathy%2F17%2Fen</id>
	<title>Translations:Diabetic nephropathy/17/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ADiabetic_nephropathy%2F17%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Diabetic_nephropathy/17/en&amp;action=history"/>
	<updated>2026-09-15T17:37:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Diabetic_nephropathy/17/en&amp;diff=121622&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Diabetic_nephropathy/17/en&amp;diff=121622&amp;oldid=prev"/>
		<updated>2024-02-26T15:30:22Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;===Staging===&lt;br /&gt;
To clinically stage the degree of damage in this (and any) kidney disease, the serum creatinine is determined and used to calculate the estimated glomerular filtration rate ([[Estimated Glomerular Filtration Rate|eGFR]]). Normal eGFR is equal to or greater than 90ml/min/1.73 m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;.&lt;br /&gt;
On biopsy, the following classification has been suggested by Tervaert &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039;:&lt;br /&gt;
{|class=wikitable&lt;br /&gt;
|+Histopathologic staging&lt;br /&gt;
! Class !! Description and criteria&lt;br /&gt;
|-&lt;br /&gt;
| I || Mild or nonspecific changes on light microscopy and conformed GBM&amp;lt;br&amp;gt;thickening proven by electron microscopy: GBM &amp;gt; 395 nm (female), GBM &amp;gt; 430 nm (male).&lt;br /&gt;
|-&lt;br /&gt;
| IIa&lt;br /&gt;
|&lt;br /&gt;
* Mild mesangial expansion in &amp;gt;25% of the observed mesangium.&lt;br /&gt;
* Area of mesangial proliferation &amp;lt; area of capillary cavity.&lt;br /&gt;
|-&lt;br /&gt;
| IIb&lt;br /&gt;
|&lt;br /&gt;
* Severe mesangial expansion in &amp;gt;25% of the observed mesangium.&lt;br /&gt;
* Area of mesangial proliferation &amp;lt; area of capillary cavity.&lt;br /&gt;
|-&lt;br /&gt;
| III&lt;br /&gt;
| At least one convincing nodular sclerosis (Kimmelstiel-Wilson lesion).&lt;br /&gt;
|-&lt;br /&gt;
| IV&lt;br /&gt;
| Advanced diabetic glomerulosclerosis in &amp;gt;50% of glomeruli.&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>